-
1h 4m 11sPart 2 | Session 3 Plenary Session 8: New technologies to treat your patients
-
1h 9sPart 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
-
1h 1m 38s
-
1h 1m 4sPart 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
-
1h 1m 28sPart 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
-
1h 1m 14s
-
1h 22sPart 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1)
-
1h 1m 19sPart 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations
-
53m 32sPart 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2)
-
1h 2m 37sPart 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
37m 5sPart 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
1h 1m 4sPart 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day 1
Part 2
Day 2
Faculty Biographies
Vijay Chopra
Senior Director of Clinical Cardiology, Heart Failure and Research
Dr Vijay Chopra is the Senior Director of Clinical Cardiology, Heart Failure and Research in the Heart Failure Programme at the Max Super Specialty Hospital in Saket, New Delhi, India. He is considered a pioneer in preventive cardiology, and has worked extensively in the management of patients with advanced heart disease. He has been principal investigator of numerous international clinical trials.
Dr Chopra's research interests include preventive cardiology, heart failures and advanced heart diseases. He was awarded the Kutumbiah Prize in Clinical Medicine from CMC Vellore in 1972. He founded the Heart Failure Association of India (HFAI), and served as its first president from 2014 - 2019.
Dr Chopra has over 50 publications in peer-reviewed journals.
Dr Vijay Chopra is an Editorial Board member of Cardiac Failure Review and may be contacted
Friedrich Koehler
Head of the Centre for Cardiovascular Telemedicine, Senior Physician at the Medical Department of Cardiology and Angiology
Jasper J Brugts
Heart Failure Cardiologist
Dr Jasper J Brugts is a Heart Failure Cardiologist at Erasmus University Medical Centre, Rotterdam, NL.
He is also a clinical epidemiologist and clinical trialist.
William T Abraham
Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
William T. Abraham, MD, grew up in western Pennsylvania near Pittsburgh, where he developed an early interest in science and medicine. He is married and has devoted the majority of his professional life to academic medicine, cardiovascular research, and the care of patients with advanced heart disease in the United States.
Academic History
Dr Abraham earned his medical degree from Harvard Medical School in Boston, Massachusetts. Following graduation, he completed residency training in Internal Medicine and fellowships in Cardiovascular Disease and Advanced Heart Failure and Transplant Cardiology at the University of Colorado Health Sciences Center. He is board certified in Internal Medicine and in Advanced Heart Failure and Transplant Cardiology.
Career Overview
Dr Abraham is a Professor of Internal Medicine, Physiology and Cell Biology and a College of Medicine Distinguished Professor at The Ohio State University College of…
